John Parkinson is the assistant managing editor for Contagion. Prior to joining MJH Life Sciences in 2020, he has covered a variety of fields and markets including diabetes, oncology, ophthalmology, IT, travel, and local news. You can email him at jparkinson@mjhlifesciences.com.
New Formulation of Cabotegravir for HIV Treatment Can be Dosed at Intervals of at Least 4 Months
March 4th 2024In a phase 1 study, the investigational therapy known as cabotegravir ultra long-acting (CAB-ULA), showed positive pharmacokinetic, tolerability, and safety data supporting a prospective move to the next stage of clinical development.
Read More
Measles Outbreaks: How Complacency Associated With Immunizations and COVID-19 are Driving Increases
February 29th 2024Reduced childhood immunizations because of personal beliefs and fears, and the quarantine's effect, along with a lack of knowledge about transmissibility and the seriousness of measles are causing unnecessary suffering and danger to people, especially in children.
Read More
CDC ACIP Votes to Recommend an Additional Dose of COVID-19 Vaccine in Seniors
February 28th 2024With today's vote, the federal agency’s Advisory Committee on Immunization Practices (ACIP) is now recommending people 65 years of age and older get 1 more dose of the 2023-2024 formula of the COVID-19 vaccine.
Read More
FDA Issues a CRL for Venatorx Pharmaceuticals’ Antibiotic for Treatment of Complicated UTI
February 23rd 2024The federal agency did not request further trials for the investigational therapy, cefepime-taniborbactam, but wanted more information about its chemistry, manufacturing, and controls.
Read More
Investigational Hepatitis B Therapy is Granted FDA Fast-Track Status
February 13th 2024GSK’s bepirovirsen received this designation, and the company has its sights on the therapy potentially providing a functional cure for the millions of people around the world who are affected by this form of viral hepatitis.
Read More
CDC Report: Syphilis Incidence Rate Continues to Increase and Shows Rising Trend Over Several Years
January 30th 2024The latest data on sexually transmitted infections (STI) shows a large increase in syphilis incidence rates year-over year, where others were either flat or saw a slight decrease. The report also shows an ongoing rise of syphilis cases over the long-term.
Read More
Differences in Central Line Associated Bloodstream Infections Prior to and During the Pandemic
January 29th 2024Investigators looked at potential risk factors as incidence rates changed over time after the introduction of COVID-19 and whether race and other variables affected the potential development of these infections.
Read More